NCT04713449 is a NA clinical trial of Empowered Survivor Online in Oral Cancer, sponsored by Rutgers, The State University of New Jersey.

Who is sponsoring NCT04713449?

NCT04713449 is sponsored by Rutgers, The State University of New Jersey.

What drugs are being tested in NCT04713449?

Interventions in NCT04713449: Empowered Survivor Online, Springboard Beyond Cancer, Survey Administration.

What condition does NCT04713449 study?

NCT04713449 studies Oral Cancer, Oropharyngeal Cancer, Head and Neck Cancer.

Is NCT04713449 still recruiting?

NCT04713449 is currently active, enrolled. Last updated 23 February 2026.

Last reviewed 2026-02-23 · How we verify

NCT04713449

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial

Active, enrolled NA Last updated 23 February 2026

What this trial tests

NA trial testing Empowered Survivor Online in Oral Cancer in 643 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

19 January 2021

Primary endpoint
28 August 2025

28 February 2027

Quick facts

Lead sponsor	Rutgers, The State University of New Jersey
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	643
Start date	19 January 2021
Primary completion	28 August 2025
Estimated completion	28 February 2027
Sites	1 location across United States

Drugs / interventions tested

Empowered Survivor Online
Springboard Beyond Cancer
Survey Administration

Conditions studied

Oral Cancer — all drugs for Oral Cancer →
Oropharyngeal Cancer — all drugs for Oropharyngeal Cancer →
Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Rutgers, The State University of New Jersey

Who can join

Adults 18 to 89, any sex, with Oral Cancer or Oropharyngeal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Project's goal is evaluate an online tool the research team created called Empowered Survivor (ES) against a free online self-management intervention developed for cancer survivors by the National Cancer Institute and the American Cancer Society called Springboard Beyond Cancer.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Prevalence and correlates of fear of recurrence among oral and oropharyngeal cancer survivors.
Manne SL, Hudson SV, Preacher KJ, Imanguli M, et al · · 2025 · cited 6× · PMID 37584880 · DOI 10.1007/s11764-023-01449-3
Enhancing Self-care Among Oral Cancer Survivors: Protocol for the Empowered Survivor Trial.
Manne SL, Imanguli M, Kashy D, Pesanelli M, et al · · 2023 · PMID 36662561 · DOI 10.2196/39996

Verify or expand the search:

Other recruiting trials for Oral Cancer

Currently open trials in the same condition.

NCT07509619 — AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients · recruiting
NCT07260344 — Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral · NA · recruiting
NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
NCT07095608 — Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain · NA · recruiting
NCT07296250 — Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT · NA · recruiting

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04713449 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 23 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04713449.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing